GlaxoSmithKline Pharmaceuticals Ltd.

BSE: 500660 | NSE: GLAXO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE159A01016 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

GlaxoSmithKlin GlaxoSmithKline Pharmaceuticals Ltd. | BSE 2290.00 20.20 (0.89%) | NSE 2278.50 5.90 (0.26%) | Trade | Add

BSE Live

Jan 21, 16:01

2290.00 20.20 (0.89%)

Volume

AVERAGE VOLUME

5-Day

2,772

10-Day

2,874

30-Day

6,335

3,971

Prev. Close

2269.80
Open Price

2269.90

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 21, 15:56

2278.50 5.90 (0.26%)

Volume

AVERAGE VOLUME

5-Day

59,490

10-Day

66,866

30-Day

82,747

100,394

Prev. Close

2272.60
Open Price

2270.10

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2278.50 (76)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
Per Share Ratios
Basic EPS (Rs.)	6.50	25.11	41.56	39.76	44.22
Diluted EPS (Rs.)	6.50	25.11	41.56	39.76	44.22
Cash EPS (Rs.)	11.38	27.98	46.04	42.87	47.16
Book Value [ExclRevalReserve]/Share (Rs.)	108.62	126.47	245.56	239.45	260.28
Book Value [InclRevalReserve]/Share (Rs.)	108.62	126.47	245.56	239.45	260.28
Dividend / Share(Rs.)	40.00	20.00	35.00	30.00	50.00
Revenue from Operations/Share (Rs.)	190.35	184.68	339.03	342.73	322.91
PBDIT/Share (Rs.)	43.45	41.79	66.34	58.08	70.67
PBIT/Share (Rs.)	38.57	38.92	61.86	54.97	67.72
PBT/Share (Rs.)	19.04	39.18	63.94	60.34	67.99
Net Profit/Share (Rs.)	6.50	25.11	41.56	39.76	44.22
Profitability Ratios
PBDIT Margin (%)	22.82	22.62	19.56	16.94	21.88
PBIT Margin (%)	20.26	21.07	18.24	16.03	20.97
PBT Margin (%)	10.00	21.21	18.85	17.60	21.05
Net Profit Margin (%)	3.41	13.59	12.25	11.60	13.69
Return on Networth / Equity (%)	5.98	19.85	16.92	16.60	16.98
Return on Capital Employed (%)	30.68	26.82	14.85	14.61	15.00
Return on Assets (%)	3.51	10.88	8.87	11.14	12.19
Total Debt/Equity (X)	0.00	0.00	0.00	0.00	0.00
Asset Turnover Ratio (%)	102.97	80.03	72.42	96.08	89.07
Liquidity Ratios
Current Ratio (X)	1.75	1.37	1.35	2.30	3.73
Quick Ratio (X)	1.27	1.04	1.04	1.70	2.82
Inventory Turnover Ratio (X)	6.68	6.43	5.74	6.82	5.24
Dividend Payout Ratio (NP) (%)	307.86	69.69	72.19	125.75	141.34
Dividend Payout Ratio (CP) (%)	175.79	62.55	65.16	116.63	132.52
Earnings Retention Ratio (%)	-207.86	30.31	27.81	-25.75	-41.34
Cash Earnings Retention Ratio (%)	-75.79	37.45	34.84	-16.63	-32.52
Valuation Ratios
Enterprise Value (Cr.)	20,028.90	20,865.08	16,384.86	22,286.72	30,816.56
EV/Net Operating Revenue (X)	6.21	6.67	5.71	7.68	11.27
EV/EBITDA (X)	27.21	29.47	29.16	45.30	51.48
MarketCap/Net Operating Revenue (X)	6.54	7.04	6.15	7.98	11.77
Retention Ratios (%)	-207.86	30.30	27.80	-25.75	-41.34
Price/BV (X)	11.46	10.28	8.49	11.42	14.60
Price/Net Operating Revenue	6.54	7.04	6.15	7.98	11.77
Earnings Yield	0.01	0.02	0.02	0.01	0.01